Ardelyx (ARDX) Operating Margin (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,878.00 |
| Dec 31, 2025 | -13,322.00 |
| Sep 30, 2025 | 15,203.00 |
| Jun 30, 2025 | 3,431.00 |
| Mar 31, 2025 | -5,604.00 |
| Dec 31, 2024 | 472.00 |
| Sep 30, 2024 | 2,089.00 |
| Jun 30, 2024 | 3,501.00 |
| Mar 31, 2024 | 2,782.00 |
| Dec 31, 2023 | -9,456.00 |
| Sep 30, 2023 | 8,756.00 |
| Jun 30, 2023 | 15,482.00 |
| Mar 31, 2023 | -25,674.00 |
| Dec 31, 2022 | 46,632.00 |
| Sep 30, 2022 | 59,898.00 |
| Jun 30, 2022 | 490,386.00 |
| Mar 31, 2022 | -251,378.00 |
| Dec 31, 2021 | 17,279.00 |
| Sep 30, 2021 | -18,621.00 |
| Jun 30, 2021 | -292,822.00 |
| Mar 31, 2021 | 104,183.00 |
| Dec 31, 2020 | -89,553.00 |
| Sep 30, 2020 | 68,592.00 |
| Jun 30, 2020 | 47,618.00 |
| Mar 31, 2020 | -95,695.00 |
| Dec 31, 2019 | -10,457.00 |
| Sep 30, 2019 | 13.72 Mn |
| Dec 31, 2018 | -1.84 Mn |
| Sep 30, 2018 | 6.00 Mn |
| Jun 30, 2018 | -7.31 Mn |
| Jun 30, 2015 | 10,924.00 |
| Mar 31, 2015 | 273.00 |
| Dec 31, 2014 | -6,312.00 |
| Sep 30, 2014 | -2,904.00 |
| Jun 30, 2014 | 3,554.00 |
| Mar 31, 2014 | 303.00 |
| Dec 31, 2013 | 498.00 |
| Sep 30, 2013 | -177.00 |